CMO Dr. Andrew Hertler on the Recent FDA ODAC Meeting
New Century Health, a national leader in specialty care management, is proud to provide comprehensive oncol...
Dr. Andrew Hertler explains three key criteria for evaluating fast-tracked drugs.
Confronting the heart-wrenching, avoidable circumstances that happen in hospitals and homes every day.
Red flags cause clinical reviewers to question a radiation oncologist’s diagnosis.
Health plan clinical leaders joined us for an insightful discussion on the path toward high-value cancer care.
Home-based chemotherapy infusions may offer convenience but also raise a host of questions.
Discussing drug costs should be a core tenet of shared decision-making.
Sotunde is president and CEO of Blue Cross and Blue Shield of North Carolina.
Partnership will empower members with serious illness to articulate and advocate for the care they want.
Evidence-Based Oncology interviews our CMO about mismatches between drug costs and efficacy.
Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.
Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.
Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.
The addition of Vital Decisions’ specialized patient engagement services expected to position New Century Health to accelerate growth, improve patient care quality and increase margins.
The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.
Our chief medical officer highlights noteworthy research and results from clinical oncology's premier event.
New Century Health, a national leader in specialty care management, is proud to provide comprehensive oncology specialty management services to Neighborhood Health Plan of Rhode Island.
Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.
Senior Medical Director Fernando Villacian lays out the key tenets of an effective cardiovascular management program.
Our senior medical director speaks with Journal of Clinical Pathways about preventing inappropriate use in cardiology.
New Century Health announced that 2020 was the largest membership growth year in the 19-year history of the company.